Programme

Dr James Ferguson and Dr Matthew Armstrong, on behalf of the Birmingham Liver Unit, are pleased to invite colleagues to the Birmingham Liver Course, on 21-22 May 2020.

The Royal Colleges of Physicians have approved this event for 7 CPD credits.

This event has been endorsed by The British Association for the Study of the Liver.

BASL Logo

 

 

Programme

Detailed programme
Day 1: Thursday 21st May
Time Session
 09:30 Registration and Refreshments
 10:00 Welcome
Dr James Ferguson and Dr Matthew Armstrong
  Session 1: Controversies in Hepatology
 10:15 Dr Dhiraj Tripathi, University Hospitals Birmingham
Early TIPS for variceal bleeding
 10:35 Professor Debbie Shawcross, King's College London
Non-transplant options for refractory encephalopathy
 10:55 Dr Ewan Forrest, NHS Greater Glasgow and Clyde
Is any therapy effective for alcoholic hepatitis?
 11:15 Discussion
 11:35 Refreshments
 Session 2: Challenges in Hepatology
 12:00 Dr Andrew Holt, University Hospitals Birmingham
Palliative management of ascites and hepatic hydrothorax
 12:20 Dr James Ferguson, University Hospitals Birmingham
Pregnancy related liver disease
 12:40 Dr Nick Murphy, University Hospitals Birmingham
Which liver patient should I take to ITU? 
 13:00 Discussion
 13:20 Lunch
Session 3: State of the art-viral hepatitis
14:00 Professor David Mutimer, University of Birmingham
Can we cure Hepatitis B? 
 14.20 Miss Sally Bufton,  Hepatitis ODN Nurse/Manager, University Hospitals Birmingham
The ODN and case finding in Hepatitis C
 14:40 Dr Mark Aldersley, Leeds Teaching Hospitals
Is hepatitis E really a problem?
15:00 Discussion
15:20 Refreshments
 2020 Birmingham Liver Unit Keynote Lecture
 15:50  Professor John O'Grady, Kings College London
 Pushing the boundaries of the indications for liver transplantation
 16:35 Discussion
 18:30 Close
 
Day 2: Friday 22nd May 
Time Session
09:30 Registration
10:00 Welcome
Dr James Ferguson and Dr Matthew Armstrong
Session 5: NAFLD
10:15 Professor Emmanouil  Tsochatzis, UCL
Primary care NAFLD pathways
10:35 Dr William Alazawi, Barts Health and Queen Mary University of London
Does NAFLD confer an additional cardiovascular risk?
10:55 Dr Matthew Armstrong, University Hospitals Birmingham
Treatment options for the NAFLD patient with significant fibrosis
11:15 Discussion
11:35 Refreshments

Session 6: Case presentations from the Birmingham Liver Unit

Chair: Dr Neil Rajoriya, University Hospitals Birmingham

12:00 Case 1: Dr Sara Mahgoub
12:20 Case 2: Dr Alex Boyd
12:40 Case 3: Dr Amritpal Dhaliwal
13:00 Discussion
13:20 Lunch and Close

Programme subject to change.